Tufaro A - Search Results

1

A CT-based transfer learning approach to predict NSCLC recurrence: The added-value of peritumoral region.

Bove S, Fanizzi A, Fadda F, Comes MC, Catino A, Cirillo A, Cristofaro C, Montrone M, Nardone A, Pizzutilo P, Tufaro A, Galetta D, Massafra R. Bove S, et al. Among authors: tufaro a. PLoS One. 2023 May 2;18(5):e0285188. doi: 10.1371/journal.pone.0285188. eCollection 2023. PLoS One. 2023. PMID: 37130116 Free PMC article.

2

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.

Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.

3

Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study.

Garrisi VM, Tufaro A, Trerotoli P, Bongarzone I, Quaranta M, Ventrella V, Tommasi S, Giannelli G, Paradiso A. Garrisi VM, et al. Among authors: tufaro a. PLoS One. 2012;7(11):e49631. doi: 10.1371/journal.pone.0049631. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226214 Free PMC article.

4

A strengthening the reporting of observational studies in epidemiology (STROBE): Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?

Dellino M, Gargano G, Tinelli R, Carriero C, Minoia C, Tetania S, Silvestris E, Loizzi V, Paradiso A, Casamassima P, Tufaro A, Cormio G, Garrisi VM. Dellino M, et al. Among authors: tufaro a. Medicine (Baltimore). 2021 Feb 5;100(5):e24485. doi: 10.1097/MD.0000000000024485. Medicine (Baltimore). 2021. PMID: 33592901 Free PMC article.

5

Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.

Paradiso AV, De Summa S, Loconsole D, Procacci V, Sallustio A, Centrone F, Silvestris N, Cafagna V, De Palma G, Tufaro A, Garrisi VM, Chironna M. Paradiso AV, et al. Among authors: tufaro a. J Med Internet Res. 2020 Oct 30;22(10):e19152. doi: 10.2196/19152. J Med Internet Res. 2020. PMID: 33031048 Free PMC article.

6

Proteomic profile in familial breast cancer patients.

Garrisi VM, Tommasi S, Facchiano A, Bongarzone I, De Bortoli M, Cremona M, Cafagna V, Abbate I, Tufaro A, Quaranta M, Paradiso A. Garrisi VM, et al. Among authors: tufaro a. Clin Biochem. 2013 Feb;46(3):259-65. doi: 10.1016/j.clinbiochem.2012.11.003. Epub 2012 Nov 13. Clin Biochem. 2013. PMID: 23159292

7

Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling.

Chillà A, Anceschi C, Frediani E, Scavone F, Del Rosso T, Pelagio G, Tufaro A, De Palma G, Del Rosso M, Fibbi G, Chiarugi P, Laurenzana A, Margheri F. Chillà A, et al. Among authors: tufaro a. J Transl Med. 2023 Feb 9;21(1):102. doi: 10.1186/s12967-023-03954-6. J Transl Med. 2023. PMID: 36759828 Free PMC article.

8

Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.

Achille G, Garrisi VM, Russo S, Guastamacchia E, Giagulli VA, Schirosi L, Daniele A, Tufaro A, Cafagna V, Centrone M, Simone G, Abbate I, Triggiani V. Achille G, et al. Among authors: tufaro a. Endocr Metab Immune Disord Drug Targets. 2017;17(3):213-218. doi: 10.2174/1871530317666170531092501. Endocr Metab Immune Disord Drug Targets. 2017. PMID: 28558632

9

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.

Digennaro M, Sambiasi D, Tommasi S, Pilato B, Diotaiuti S, Kardhashi A, Trojano G, Tufaro A, Paradiso AV. Digennaro M, et al. Among authors: tufaro a. Hered Cancer Clin Pract. 2017 May 25;15:7. doi: 10.1186/s13053-017-0067-8. eCollection 2017. Hered Cancer Clin Pract. 2017. PMID: 28559958 Free PMC article.

10

Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari.

De Palma G, Bolondi G, Tufaro A, Pelagio G, Brando G, Vitale D, Paradiso AV. De Palma G, et al. Among authors: tufaro a. Cancers (Basel). 2022 Jul 16;14(14):3460. doi: 10.3390/cancers14143460. Cancers (Basel). 2022. PMID: 35884521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page